📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Epigenetic reprogramming enables NF1A/B oncogenic role in SHH medulloblastoma. (2024)

First Author: Badodi S

Attributed to: A BMI1/CHD7 signature in medulloblastoma with poor prognosis. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.devcel.2024.07.002

PubMed Identifier: 39255772

Publication URI: http://europepmc.org/abstract/MED/39255772

Type: Journal Article/Review

Volume: 59

Parent Publication: Developmental cell

Issue: 17

ISSN: 1534-5807